Sale!

DNAJC19 Gene Cardiomyopathy dilated with ataxia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DNAJC19 Gene Cardiomyopathy Dilated with Ataxia Genetic Test” is a specialized diagnostic tool used to identify mutations in the DNAJC19 gene, which are associated with a rare genetic disorder. This condition is characterized by dilated cardiomyopathy, a heart condition that affects the heart’s ability to pump blood efficiently, coupled with ataxia, a neurological sign consisting of lack of voluntary coordination of muscle movements. The test is crucial for early detection, which can lead to better management of the symptoms and a more targeted approach to treatment.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The sample is then analyzed to detect any genetic abnormalities in the DNAJC19 gene. Given the complexity of the test and the expertise required to interpret the results, it is priced at 4400 AED.

This test is particularly important for individuals with a family history of dilated cardiomyopathy or ataxia, as it can provide essential information for genetic counseling and guide decisions regarding family planning. Moreover, it can also help in the identification of other family members who may be at risk of developing the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAJC19 Gene Cardiomyopathy Dilated with Ataxia Genetic Test

Welcome to DNA Labs UAE, where we offer the DNAJC19 Gene Cardiomyopathy Dilated with Ataxia Genetic Test. This test is designed to identify mutations or variants in the DNAJC19 gene that may be responsible for the development of dilated cardiomyopathy with ataxia (DCMA).

Test Components

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information

Before undergoing the DNAJC19 Gene Cardiomyopathy Dilated with Ataxia Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the DNAJC19 Gene Cardiomyopathy Dilated with Ataxia NGS Genetic DNA Test gene DNAJC19.

Test Details

The DNAJC19 gene is associated with a rare genetic disorder called dilated cardiomyopathy with ataxia (DCMA). This condition is characterized by the development of dilated cardiomyopathy, where the heart becomes enlarged and weakened, leading to heart failure. Individuals with DCMA may also experience ataxia, which is a lack of coordination and balance.

NGS genetic testing, also known as next-generation sequencing, is a high-throughput method used to analyze multiple genes simultaneously. In the context of DCMA, NGS genetic testing can be used to identify mutations or variants in the DNAJC19 gene that may be responsible for the development of the condition.

By performing NGS genetic testing, healthcare professionals can identify individuals who are at risk of developing DCMA, provide early diagnosis, and offer appropriate management and treatment options. Genetic testing can also help identify carriers of the condition and provide genetic counseling to individuals and families.

It is important to note that genetic testing should always be done under the supervision of a healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name DNAJC19 Gene Cardiomyopathy dilated with ataxia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DNAJC19 Gene Cardiomyopathy, dilated with ataxia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DNAJC19 Gene Cardiomyopathy, dilated with ataxia NGS Genetic DNA Test gene DNAJC19
Test Details

The DNAJC19 gene is associated with a rare genetic disorder called dilated cardiomyopathy with ataxia (DCMA). This condition is characterized by the development of dilated cardiomyopathy, which is a condition where the heart becomes enlarged and weakened, leading to heart failure. Additionally, individuals with DCMA may also experience ataxia, which is a lack of coordination and balance.

NGS genetic testing, also known as next-generation sequencing, is a high-throughput method used to analyze multiple genes simultaneously. In the context of DCMA, NGS genetic testing can be used to identify mutations or variants in the DNAJC19 gene that may be responsible for the development of the condition.

By performing NGS genetic testing, healthcare professionals can identify individuals who are at risk of developing DCMA, provide early diagnosis, and offer appropriate management and treatment options. Additionally, genetic testing can also help in identifying carriers of the condition and provide genetic counseling to individuals and families.

It is important to note that genetic testing should always be done under the supervision of a healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.